Search Results

Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphoma.

• Authors : Fukae M; Daiichi Sankyo Co., Ltd., Tokyo, Japan.; Rogers J

Subjects: Bayes Theorem* ; Leukemia-Lymphoma, Adult T-Cell*/Leukemia-Lymphoma, Adult T-Cell*/Leukemia-Lymphoma, Adult T-Cell*/drug therapy ; Dose-Response Relationship, Drug*

• Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Oct; Vol. 13 (10), pp. 1655-1669. Date of Electronic Publication: 2024 Aug 18.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Differential impact of asparaginase discontinuation on outcomes of children with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

• Authors : Ishida H; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.; Imamura T

Subjects: Asparaginase*/Asparaginase*/Asparaginase*/therapeutic use ; Asparaginase*/Asparaginase*/Asparaginase*/administration & dosage ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy

• Source: Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (12), pp. e7246.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell Lymphoma.

• Authors : Sanagawa A; Department of Pharmacy, Nagoya City University Hospital, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. .; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8602, Japan. .

Subjects: Bexarotene*/Bexarotene*/Bexarotene*/adverse effects ; Bexarotene*/Bexarotene*/Bexarotene*/therapeutic use ; Bexarotene*/Bexarotene*/Bexarotene*/administration & dosage

• Source: Drugs in R&D [Drugs R D] 2024 Jun; Vol. 24 (2), pp. 227-238. Date of Electronic Publication: 2024 Jun 13.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet

Record details

A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan.

• Authors : Owatari, Satsuki¹ (AUTHOR); Tokunaga, Masahito² (AUTHOR); Nakamura, Daisuke³ (AUTHOR)

• Source: Leukemia & Lymphoma. Apr2023, Vol. 64 Issue 4, p865-873. 9p.

Record details

Nationwide Hospital-Based Survey of Adult T-Cell Leukemia/Lymphoma in Japan.

• Authors : Kato, Takeharu¹ (AUTHOR) ; Imaizumi, Yoshitaka² (AUTHOR) ; Miyazaki, Yasushi² (AUTHOR)

Subjects: *ADULT T-cell leukemia; *LYMPHOMAS; *OVERALL survivalJAPAN

• Source: Viruses (1999-4915). Apr2022, Vol. 14 Issue 4, pN.PAG-N.PAG. 8p.

Record details

Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.

• Authors : Kameda, Takuro¹ (AUTHOR) ; Shide, Kotaro¹ (AUTHOR) ; Tahira, Yuki¹ (AUTHOR)

Subjects: *ADULT T-cell leukemia; *LYMPHOMAS; *BLOOD urea nitrogenJAPAN

• Source: Viruses (1999-4915). Apr2022, Vol. 14 Issue 4, pN.PAG-N.PAG. 9p.

Record details

Valemetostat: First approval as a dual inhibitor of EZH1/2 to treat adult T-cell leukemia/lymphoma.

• Authors : Fangzhou Dou¹; Zhenxue Tian²; Xu Yang²

• Source: Drug Discoveries & Therapeutics. Dec2022, Vol. 16 Issue 6, p297-299. 3p.

Record details

Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.

• Authors : Yamasaki, Satoshi¹ (AUTHOR); Iida, Hiroatsu² (AUTHOR); Yoshida, Isao³ (AUTHOR)

• Source: Leukemia & Lymphoma. Apr2021, Vol. 62 Issue 4, p819-827. 9p.

Record details

Measures for the Prevention of Mother-to-Child Human T-Cell Leukemia Virus Type 1 Transmission in Japan: The Burdens of HTLV-1-Infected Mothers.

• Authors : Uchimaru K; Department of Tumor Cell Biology, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo 1088639, Japan.; Itabashi K

Subjects: Human T-lymphotropic virus 1* ; Leukemia, T-Cell*; Humans

• Source: Viruses [Viruses] 2023 Sep 26; Vol. 15 (10). Date of Electronic Publication: 2023 Sep 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Efficacy and safety of single-agent pralatrexate for treatment of angioimmunoblastic T-cell lymphoma after failure of first line therapy: a pooled analysis.

• Authors : Zhu, Jun¹ (AUTHOR); Yeoh, Ee Min² (AUTHOR) ; Maeda, Yoshinobu³ (AUTHOR)

• Source: Leukemia & Lymphoma. Sep2020, Vol. 61 Issue 9, p2145-2152. 8p.

Record details